Synapse Open Synapse
Biology

Alethio raises $90M to target rare blood cancers

BioPharma Dive · · 2 min read

The startup is working on a medicine one of its investors claimed could have a broader reach than other approved drugs for a group of conditions known as myeloproliferative neoplasms.

Latest from BioPharma Dive